causal

Pharma Outsourcing Driven by FDA Compliance Costs

Many innovative new drugs come from smaller pharmaceutical companies that outsource the testing and FDA-compliance phase to large firms, because the FDA's testing requirements involve such large fixed costs that small firms cannot afford them, making the large firm's specialty essentially regulatory compliance and taking products to scale.

causalpending

Speaker

Russ Roberts

Evidence Quote

“in the case of pharmaceuticals with complying with FDA... requirements... small firms can't afford it. So they outsource that part to the larger company.”

Source

Timothy Taylor on Government vs. Business— EconTalk
Created: 6/13/2026, 12:15:52 AM

Your notes

Loading notes...